RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis AI Analysis of CYTK
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Cytokinetics stock price up 1.61% on Friday
(Updated on Nov 01, 2024)

Sell candidate since Oct 23, 2024 Loss -2.30%

The Cytokinetics stock price gained 1.61% on the last trading day (Friday, 1st Nov 2024), rising from $51.00 to $51.82. During the last trading day the stock fluctuated 2.53% from a day low at $51.07 to a day high of $52.36. The price has fallen in 7 of the last 10 days and is down by -5.73% for this period. Volume fell on the last day by -106 thousand shares and in total, 858 thousand shares were bought and sold for approximately $44.45 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.65% during the next 3 months and, with a 90% probability hold a price between $45.33 and $52.50 at the end of this 3-month period.

CYTK Signals & Forecast

There are mixed signals in the stock today. The Cytokinetics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $53.75. On a fall, the stock will find some support from the short-term average at $51.66. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Thursday, October 31, 2024, and so far it has risen 1.61%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Cytokinetics stock

Cytokinetics finds support from accumulated volume at $51.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.29 between high and low, or 2.53%. For the last week, the stock has had daily average volatility of 2.20%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CYTK) For The Upcoming Trading Day Of Monday 4th

For the upcoming trading day on Monday, 4th we expect Cytokinetics to open at $51.75, and during the day (based on 14 day Average True Range), to move between $50.16 and $53.48, which gives a possible trading interval of +/-$1.66 (+/-3.21%) up or down from last closing price. If Cytokinetics takes out the full calculated possible swing range there will be an estimated 6.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $51.32 (0.96%) than the resistance at $53.77 (3.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Cytokinetics will release earnings AMC on Wednesday, November 06, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.25. We will update the financials statements for Cytokinetics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.07% in the first trading day after earnings release.

Is Cytokinetics stock A Buy?

Cytokinetics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.381 Sell Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on November 4, 2024 - $51.75 ( 0.135%).

Trading levels for CYTK

Fibonacci Support & Resistance Levels

Level Price
R3 53.04 2.35%
R2 52.55 1.40%
R1 52.24 0.82%
Price 51.82
S1 51.26 -1.09%
S2 50.95 -1.67%
S3 50.46 -2.62%

Accumulated Volume Support & Resistance Levels

Level Price
R3 56.16 8.38%
R2 55.60 7.29%
R1 53.77 3.76%
Price 51.82
S1 51.32 -0.96%
S2 51.22 -1.16%
S3 51.00 -1.58%

FAQ

What is the symbol for Cytokinetics Stock and on which exchange is it traded?
The symbol for Cytokinetics is CYTK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cytokinetics Stock?
Cytokinetics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Cytokinetics Stock?
Cytokinetics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cytokinetics Stock.

What's the current price of Cytokinetics Stock?
As of the end of day on the Nov 01, 2024, the price of an Cytokinetics (CYTK) share was $51.82.

What is the 52-week high and low for Cytokinetics Stock?
The 52-week high for Cytokinetics Stock is $110.00 and the 52-week low is $30.68.

What is the market capitalization of Cytokinetics Stock?
As of the Nov 01, 2024, the market capitalization of Cytokinetics is 6.037B.

When is the next earnings date for Cytokinetics?
The upcoming earnings date for Cytokinetics is Nov 06, 2024.
Click to get the best stock tips daily for free!
ABOUT CYTOKINETICS
Cytokinetics
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati...
GOLDEN STAR
Ticker Change Signal Date
NBIX
$116.19
5.18% Oct 29
W
WTW
$292.18
2.44% Oct 29
I
INST
$23.52
0.213% Oct 29
SRCL
$60.88
1.81% Oct 28
EQC
$19.81
0.202% Oct 28

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE